Chronological Changes in Neutrophil/lymphocyte Ratio in Advanced Gastric Cancer Patients Treated with Nivolumab: a Report of Nine Cases

BACKGROUND: Nivolumab has been approved for use in advanced gastric cancer (GC) after third-line chemotherapy in Japan. However, it remains difficult to predict favorable nivolumab response before treatment. METHODS: We evaluated the clinical course with a focus on the chronological changes in neutr...

Full description

Saved in:
Bibliographic Details
Published in:Asian Pac J Cancer Prev
Main Authors: Nakamura, Naohiko, Kinami, Shinichi, Fujita, Jun, Kaida, Daisuke, Tomita, Yasuto, Miyata, Takashi, Fujita, Hideto, Takamura, Hiroyuki, Ueda, Nobuhiko, Kosaka, Takeo
Format: Artigo
Language:Inglês
Published: West Asia Organization for Cancer Prevention 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7798180/
https://ncbi.nlm.nih.gov/pubmed/33112554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.10.2955
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items